Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical ...

Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its ...

Opella reaches study milestone for Cialis Paris1, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its ...

Cialis, however, offers a broader spectrum of dosage options ... for treating ED but are also prescribed to help manage benign prostatic hyperplasia (BPH), a common condition in older men that causes ...

"We are now in the golden era of BPH/BPO for both diagnostics and therapeutics," says Wayne Kuang, MD. In this video, Wayne Kuang, MD, shares his thoughts on what advances in benign prostatic ...

DEAR DR. ROACH: I am a 63-year-old male in good health. A few weeks back, I could not urinate while standing. The only way I could was by laying on my side, and it was very painful with a burning ...

Although Cialis is widely known as a treatment for ED, it’s also approved by the FDA to treat benign prostatic hyperplasia. An enlarged prostate is common in older men and typically carries ...

“The FDA’s expanded approval of Gemtesa is an important milestone for the men with unresolved symptoms of OAB while being treated for BPH, which underscores our urgency to deliver for those ...

It is vital to discuss this with a doctor before commencing the use of Cialis. Severity of ED or BPH Symptoms: Individuals with milder symptoms might find the 2.5 mg or 5 mg daily dose sufficient.